Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
:KVUE
KVUE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.15 - $25.17
Previous CloseN/A
Volume2.33M
Average Volume (3M)24.01M
Market Cap
$35.02B
Enterprise Value$47.93B
Total Cash (Recent Filing)$1.07B
Total Debt (Recent Filing)$8.74B
Price to Earnings (P/E)24.8
Beta0.29
Next Earnings
Oct 23, 2025EPS Estimate
0.27Last Dividend Ex-Date
Aug 13, 2025Dividend Yield4.51%
Share Statistics
EPS (TTM)0.29
Shares Outstanding1,919,070,000
10 Day Avg. Volume37,801,894
30 Day Avg. Volume24,013,472
Financial Highlights & Ratios
PEG Ratio-0.98
Price to Book (P/B)4.20
Price to Sales (P/S)2.62
P/FCF Ratio30.38
Enterprise Value/Market Cap1.37
Enterprise Value/Revenue3.17
Enterprise Value/Gross Profit5.46
Enterprise Value/Ebitda15.78
Forecast
1Y Price Target
$22.50Price Target Upside24.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst reiterates a Buy rating, seeing a widening valuation discount as a particularly attractive entry point.
Brand ValueTylenol constitutes a key profit center and sits at the core of Kenvue’s business, being the 2nd largest brand with ~15% of US sales.
Legal RiskThe legal risk is minimal after the mass tort around the same issue was essentially shut down.
Bears Say
Consumer ConcernsInvestors may get concerned with consumers getting worried about taking Tylenol or any acetaminophen products.
Market PressureRenewed stock weakness on potential Tylenol risk.
Regulatory UncertaintyA change in position from HHS/FDA on causality could potentially embolden plaintiff litigators to pursue new avenues to sue manufacturers or retailers.
Kenvue, Inc. News
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.14 and its highest was $25.17 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $35.02B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Oct 23, 2025 which is in 35 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on Jul 14, 2025. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.282 by $0.008.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.207 which represents an annual dividend yield of 4.51%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.27.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,919,070,000 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.29 in its last earnings report, beating expectations of $0.282. Following the earnings report the stock price went up 2.223%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
Kenvue, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.50 (24.10% Upside)
$22.50 (24.10% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 32.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 5.4%
Last 30 Days ▲ 5.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.54%
12-Months-Change
Fundamentals
Return on Equity
13.56%
Trailing 12-Months
Asset Growth
2.61%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue, Inc. (KVUE) is a prominent player in the consumer health industry, specializing in the development, production, and marketing of a diverse range of health and wellness products. The company operates across several sectors, including over-the-counter medications, skincare, and other personal care products. Kenvue is committed to enhancing consumer health by providing innovative and reliable solutions that cater to the evolving needs of its global customer base.
KVUE Company Deck
KVUE Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted Kenvue's strengths in market share gains and leadership improvements but was overshadowed by underwhelming financial performance and challenges in key markets. The revised guidance and focus on strategic alternatives suggest a period of transition and uncertainty.View all KVUE earnings summariesKVUE Revenue Breakdown
42.23% Self Care
30.33% Essential Health
27.43% Skin Health and Beauty
KVUE Stock 12 Month Forecast
Average Price Target
$22.50
▲(24.10% Upside)
Technical Analysis
Ownership Overview
1.13% Insiders
33.69% Mutual Funds
17.41% Other Institutional Investors
19.21% Public Companies and Individual Investors